ExodusPoint Capital Management, LP - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$309
-99.4%
98,422
+634.4%
0.00%
+200.0%
Q3 2022$56,0000.0%13,402
+18.5%
0.00%0.0%
Q1 2022$56,000
-59.1%
11,306
-17.2%
0.00%
-50.0%
Q3 2021$137,000
-4.2%
13,662
+35.3%
0.00%0.0%
Q2 2021$143,00010,1010.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,784,850$15,064,00062.56%
Versant Venture Management, LLC 2,215,384$8,817,228,0004.36%
SV Health Investors, LLC 628,236$2,500,0001.54%
DELTEC ASSET MANAGEMENT LLC 724,747$2,885,0000.80%
Endurant Capital Management LP 232,727$926,0000.49%
NOTTINGHAM ADVISORS, INC. 146,946$1,011,0000.15%
JGP Global Gestao de Recursos Ltda. 12,568$50,0000.06%
Man Group plc 1,187,508$4,726,0000.02%
Dynamic Technology Lab Private Ltd 21,077$84,0000.02%
NewEdge Advisors, LLC 36,250$144,0000.01%
View complete list of OCULAR THERAPEUTIX INC shareholders